awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38839151-A65204ED-956E-49B7-9560-80155C7398C9
Q38839151-A65204ED-956E-49B7-9560-80155C7398C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38839151-A65204ED-956E-49B7-9560-80155C7398C9
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer.
P2860
Q38839151-A65204ED-956E-49B7-9560-80155C7398C9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38839151-A65204ED-956E-49B7-9560-80155C7398C9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c3d8e49c7be0c174b364b9c562465ab8ade400b8
P2860
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.